Volume 20, Number 10—October 2014
Dispatch
Prevalence of Arcobacter Species among Humans, Belgium, 2008–2013
Anne-Marie Van den Abeele
, Dirk Vogelaers, Johan Van Hende, and Kurt Houf
, Dirk Vogelaers, Johan Van Hende, and Kurt Houf
Table 2
Microbiological and clinical details of 86 patients whose fecal samples contained Arcobacter spp., 2008–2013, Belgium
| Characteristic | Arcobacter spp. samples, N = 89 |
||
|---|---|---|---|
| A. butzleri, n = 49* (55%) |
A. cryaerophilus, n = 38 (43%) |
A. thereius, n = 2 (2%) |
|
| No. (%) | No. (%) | No. (%) | |
| Fecal consistency | |||
| Solid | 18 (37) | 16 (42) | 0 |
| Semisolid-liquid | 25 (51) | 22 (58) | 1 (1) |
| Mucous | 5 (10) | 0 | 1 (1) |
| Bloody |
1 (2) |
0 |
0 |
| Clinical status | |||
| Ambulatory | 19 (39) | 32 (84) | 1 (1) |
| Hospitalized |
30 (61) |
6 (16) |
1 (1) |
| Clinical syndromes | |||
| Acute gastroenteritis | 19 (39) | 30 (79) | 1 (1) |
| Coexisting medical condition | 30 (61) | 8 (21) | 1 (1) |
| Chronic colitis | 8 (15) | 2 (5) | 1 (1) |
*49 samples from 46 patients.
Page created: September 22, 2014
Page updated: September 22, 2014
Page reviewed: September 22, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.